Monogram Technologies

Monogram Technologies is a private, pre-revenue company developing a novel, integrated platform for personalized orthopedic surgery, centered on its mBôs™ robotic system and customized 3D-printed implants. The company has achieved a key regulatory milestone with FDA 510(k) clearance for its mBôs™ TKA System for total knee arthroplasty. Its strategy is to disrupt the large and established joint replacement market by offering a fully customized surgical solution, from patient-specific implant design to robotically executed bone preparation, with the goal of improving implant fit, stability, and long-term patient outcomes.

Integrated platform combining: 1) mBôs™ active surgical robotics for precision bone cuts; 2) Patient-specific, 3D-printed orthopedic implants; 3) Proprietary software utilizing machine learning for image processing, surgical planning, and workflow automation.

Monogram competes in the rapidly growing robot-assisted orthopedic surgery market against giants like Stryker (Mako), Johnson & Johnson (Velys), and Medtronic (Mazor). Its key differentiation is the combination of robotics with patient-specific implants, a strategy distinct from competitors who primarily use robotics to place standard implants. Its integration into Zimmer Biomet now pits it directly against its parent's other robotic offerings and external rivals.